Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-16 Sale | 2025-12-18 8:05 pm | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 13,187 | $22.31 | $294,202 | 193,300 (Direct) | View |
| 2025-03-12 Sale | 2025-03-13 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 2,491 | $99.64 | $248,203 | 27,812 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-09 Tax Withholding | 2026-03-11 8:08 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 275 | $16.95 | 135,320 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 830 | $16.95 | 138,518 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 1,399 | $16.95 | 226,271 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 1,619 | $16.95 | 203,080 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 408 | $16.2 | 139,348 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 450 | $16.2 | 135,595 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 4,176 | $16.2 | 204,699 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 8,125 | $0 | 204,699 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 4,485 | $16.2 | 227,670 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 8,125 | $0 | 227,670 (Direct) | View |
| 2026-02-26 Exercise | 2026-03-02 08:00 am | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 7,450 | $0 | 200,750 (Direct) | View |
| 2026-02-26 Exercise | 2026-03-02 08:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 7,450 | $13.71 | 200,750 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-27 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 1,875 | $0 | 8,125 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-27 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 1,875 | $0 | 8,125 (Direct) | View |
| 2026-01-29 Exercise | 2026-01-29 8:05 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 10,500 | $0 | 31,532 (Direct) | View |
| 2026-01-29 Exercise | 2026-01-29 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 10,500 | $13.71 | 31,532 (Direct) | View |
| 2026-01-29 Tax Withholding | 2026-01-29 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 6,780 | $21.23 | 31,532 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 8:04 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 10,500 | $0 | 207,482 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 10,500 | $13.71 | 207,482 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 6,494 | $22.17 | 207,482 (Direct) | View |
| 2025-12-18 Option Award | 2025-12-19 4:40 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 20,000,000 | $0 | 20,000,000 (Indirect) | View |
| 2025-12-01 Tax Withholding | 2025-12-10 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 158 | $20.96 | 136,045 (Direct) | View |
| 2025-12-07 Option Award | 2025-12-09 8:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S Chief Executive Officer | 489,084 | $0 | 929,391 (Direct) | View |
| 2025-11-28 Tax Withholding | 2025-12-02 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 229 | $21.12 | 139,756 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 4,582 | $18.42 | 224,030 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 143,875 | $0 | 228,612 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 118,875 | $0 | 136,203 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 143,875 | $0 | 206,487 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 118,875 | $0 | 139,985 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-06 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 6,250 | $0 | 6,250 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-06 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 6,250 | $0 | 6,250 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-06 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 6,250 | $0 | 6,250 (Direct) | View |
| 2025-07-31 Tax Withholding | 2025-08-04 8:10 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 327 | $16.42 | 17,328 (Direct) | View |
Ownership | 2025-08-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 0 | $0 | 48,686 (Direct) | View |
| 2025-05-16 Exercise | 2025-05-19 07:32 am | 2018-03-10 2027-03-10 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 12,350 | $0 | 3,216,667 (Direct) | View |
| 2025-05-16 Exercise | 2025-05-19 07:32 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 12,350 | $32.63 | 3,216,667 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-15 07:00 am | 2016-06-02 2025-06-02 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 20,246 | $0 | 3,204,317 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-15 07:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 10,500 | $13.71 | 3,204,317 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-15 07:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 9,746 | $25.18 | 3,204,317 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 8:00 pm | 2016-06-02 2025-06-02 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 9,746 | $0 | 27,812 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 9,746 | $25.18 | 27,812 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director | 7,175 | $0 | 10,017 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 7,175 | $0 | 13,055 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 7,175 | $0 | 299,486 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 491 | $100.13 | 37,754 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 24,920 | $0 | 37,754 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 5,500 | $0 | 79,256 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 3,941 | $100.13 | 79,256 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 24,920 | $0 | 79,256 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 7,175 | $0 | 30,015 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 7,175 | $0 | 13,796 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 523 | $100.13 | 49,144 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 24,920 | $0 | 49,144 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 5,500 | $0 | 101,275 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 3,463 | $100.13 | 101,275 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 8:00 pm | 2026-03-10 2035-03-10 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 24,920 | $0 | 101,275 (Direct) | View |